Cancer Detection in Dogs - With Just a Blood Draw. Blood-based cancer detection, or ‘liquid biopsy’, is now available for both dogs and humans and provides veterinarians with an exciting new tool in cancer detection and characterization. This presentation will outline the fundamental scientific advances behind this technology, including cancer genomics and next-generation sequencing-based detection of circulating tumor DNA. Clinical uses in veterinary medicine will be discussed, with a specific focus on screening for early cancer detection and aid in diagnosis.
Webinar: Integrating Canine Liquid Biopsy Testing Into Your Practice. Did you know that there is now a blood test that can detect 30 different types of cancer in dogs? "Liquid biopsy" using next-generation sequencing offers veterinarians a new option for canine cancer testing using a simple blood draw.
Join Andi Flory, DVM, DACVIM (Oncology), to review the clinical validation of a next-generation sequencing-based liquid biopsy test in over 1,000 dogs. Strategies for incorporation of this novel technology into routine clinical practice will be provided and case studies will be presented that describe real-world applications of this testing. The session will also examine ways to explain this advanced genomic technology to pet parents and how to interpret test results in the context of each patient's unique clinical presentation.
Cancer in dogs: How and when is it detected and is there room for improvement?Major veterinary medical organizations recognize the importance of early cancer detection in dogs. However, guidelines-driven screening protocols for early cancer detection are lacking and cancer is often detected at advanced stages. This webinar will examine data from over 350 cancer-diagnosed dogs to establish how the presenting complaint came to attention and led to a definitive diagnosis of cancer in these patients.Additionally, the presentation will review the typical age at which cancer is diagnosed in dogs from a cohort of over 3,000 cancer-diagnosed patients. Using this data, an “age to start cancer screening” can be recommended, based on an individual dog’s breed or weight. The webinar will conclude with a discussion of how blood-based liquid biopsy testing may offer a convenient, non-invasive, screening tool to aid in the earlier identification of cancer in dogs. The presenter is Angela McCleary-Wheeler, DVM, PhD, DACVIM (Oncology).
Title: Recent Advances in Veterinary Oncology: Updates Every General Practitioner Should Know. Description: During this webinar, Rachel Venable, DVM, MS, DACVIM (Oncology) will provide an overview of recent advances in oncology. The presentation discusses novel treatments and a new early cancer detection test. A review of the mechanism of action, study results, and uses of an oral treatment for canine lymphoma (Laverdia) along with an injectable treatment for canine mast cell tumor (Stelfonta) will be discussed. The presentation also provides a basic overview of cancer biology and introduces the fundamentals of blood-based “liquid biopsy” testing for canine cancer detection using next-generation sequencing of cell-free DNA (OncoK9). A review of the peer-reviewed clinical validation study of this testing in over 1,000 dogs is included.